1846 — EuroEyes International Eye Clinic Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.56bn
- HK$1.26bn
- HK$714.29m
- 87
- 61
- 70
- 89
Annual cashflow statement for EuroEyes International Eye Clinic, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 21.3 | 98.6 | 196 | 129 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 11 | 15 | 5.34 | 6.38 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -34.6 | -103 | -2.42 | -7.32 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 64.4 | 78.5 | 273 | 209 | — |
| Capital Expenditures | -29.2 | -38.3 | -44.5 | -56.3 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.061 | 0.204 | -15.3 | -75.5 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -29.1 | -38.1 | -59.9 | -132 | — |
| Financing Cash Flow Items | -23.7 | 0.547 | 0.542 | 2.43 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 610 | -116 | -69.2 | -102 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 639 | -25.2 | 83.8 | -66.4 | — |